The present application discloses a thermally insulating aerogel vacuum composite panel and a preparation method thereof. The preparation method includes the following steps: (1) mixing TEOS solution and a metal particle, adding a hydrophobic agent, mixing, adding ammonium trifluoroacetate solution dropwise until completely gelating to obtain a metal aerogel precursor; (2) adding the metal aerogel precursor into an acid replacement solution for replacement for 1-24 h to obtain a gel; (3) washing the gel with deionized water to obtain a neutral gel; (4) soaking the neutral gel obtained in step (3) in a first organic resin solvent; (5) pouring the neutral gel into a substrate with honeycomb structure, and aging for re-gelating to obtain a modified panel; (6) drying the modified panel to obtain a honeycomb panel; and (7) aging the honeycomb panel at room temperature for 1-24 h to obtain the vacuum composite panel.

In various embodiments, novel methods of fabricating and/or packaging aerogels are provided.

In various embodiments, novel methods of fabricating and/or packaging aerogels are provided.

Stabilised and aquated polymeric silicate compositions are described in which the compositions are poorly condensed compositions in which the silicates are resorbable and are capable of undergoing efficient dissolution to provide bioavailable soluble silicic acid. In particular, stabilised and aquated polymeric silicates are described that are capable of intravenous delivery, useful in the treatment of cancer or systemic infection, or for topical administration, e.g. in the form of a solid or semi-solid ointment useful in the treatment of wounds or the prevention of bacterial infection.

Stabilised and aquated polymeric silicate compositions are described in which the compositions are poorly condensed compositions in which the silicates are resorbable and are capable of undergoing efficient dissolution to provide bioavailable soluble silicic acid. In particular, stabilised and aquated polymeric silicates are described that are capable of intravenous delivery, useful in the treatment of cancer or systemic infection, or for topical administration, e.g. in the form of a solid or semi-solid ointment useful in the treatment of wounds or the prevention of bacterial infection.

The disclosure aims to provide a composition that is able to provide a film having excellent abrasion resistance and excellent antifouling properties. The composition contains a perfluorocarbon sulfonic acid resin or sulfonic acid salt resin thereof, a tetraalkoxysilane, and a trialkoxysilane.

The disclosure aims to provide a composition that is able to provide a film having excellent abrasion resistance and excellent antifouling properties. The composition contains a perfluorocarbon sulfonic acid resin or sulfonic acid salt resin thereof, a tetraalkoxysilane, and a trialkoxysilane.

Described herein is a coating composition comprising: (a) a zwitterionic compound comprising (i) sulfonate-functional groups and (ii) alkoxysilane groups and/or silanol-functional groups; (b) an acid-catalyzed hydrolysis product of an alkoxylsilane, wherein the acid-catalyzed hydrolysis product of an alkoxylsilane comprises at least one (i) (RO)(.sub.4-a)Si(OH).sub.a where R is a monovalent hydrocarbon group and a is an integer from 1 to 4; or (ii) an alkanol silicate acid oligomer; (c) a water-miscible organic solvent; and (d) water, along with articles thereof and methods of making the same.

Described herein is a coating composition comprising: (a) a zwitterionic compound comprising (i) sulfonate-functional groups and (ii) alkoxysilane groups and/or silanol-functional groups; (b) an acid-catalyzed hydrolysis product of an alkoxylsilane, wherein the acid-catalyzed hydrolysis product of an alkoxylsilane comprises at least one (i) (RO)(.sub.4-a)Si(OH).sub.a where R is a monovalent hydrocarbon group and a is an integer from 1 to 4; or (ii) an alkanol silicate acid oligomer; (c) a water-miscible organic solvent; and (d) water, along with articles thereof and methods of making the same.

Stabilised and aquated polymeric silicate compositions are described in which the compositions are poorly condensed compositions in which the silicates are resorbable and are capable of undergoing efficient dissolution to provide bioavailable soluble silicic acid. In particular, stabilised and aquated polymeric silicates are described that are capable of intravenous delivery, useful in the treatment of cancer or systemic infection, or for topical administration, e.g. in the form of a solid or semi-solid ointment useful in the treatment of wounds or the prevention of bacterial infection.